Lenvatinib

CAS 417716-92-8

Overview

Lenvatinib is used to treat thyroid cancer, kidney cancer, liver cancer, and advanced endometrial cancer

Anant Labs manufacture and furnish high quality Lenvatinib impurities for global markets. Our Lenvatinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Lenvatinib

CAS 417716-92-8In Stock

Technical Data

CAS417716-92-8

Mol. FormulaC₂₁H₁₉ClN₄O₄

Mol. Weight426.86 g/mol

IUPAC4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide

SMILESCOC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl

InChIInChI=1S/C21H19ClN4O4/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28)

InChI KeyWOSKHXYHFSIKNG-UHFFFAOYSA-N

Note: We are upgrading our system, Cat No will change.

Synonyms

Lenvatinib417716-92-8E7080E-7080E 7080ER-203492-00Kisplyx4-{3-Chloro-4-[(Cyclopropylcarbamoyl)amino]phenoxy}-7-Methoxyquinoline-6-Carboxamide4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamideEE083865G2